Not provided
Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 606060-HMO-CTIL |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We hypothesize that misexpression of vascular endothelial growth factor (VEGF) in the Cerebrospinal fluid of preterm infants can be used as a biomarker to predict the risk for developing white matter damage.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | |||
| 2 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
preterm infants.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Talya Dor, MD | Hadassah Medical Organization | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
CSF.